Eitan Medical Launches UK Operation

January 27, 2021

Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions has launched a UK operation to improve its support of the SapphireTM infusion pump customers, which include NHS Trusts, private hospitals and homecare providers.

Eitan Medical UK launches with a team of specialists in clinical support, integrated care support, and operations management. The UK entity will be backed by Eitan Medical’s global infrastructure, with offices across Israel, the US, and Europe.

Eitan Medical is the manufacturer of the innovative SapphireTM Infusion Pump as well as the Medtech Breakthrough Award-winning SorrelTM wearable drug delivery platform and has infusion pumps installed across more than 25 countries.

The UK operation, which aims to deliver safe patient-focused infusion solutions that improve healthcare outcomes and quality of life, brings together a team of industry experts with many years of experience in the infusion pump business. The team is reaching out to its existing customers to learn more about their experience so that it can further improve its products and services.

Kean Crispin, Sales Director at Eitan Medical UK, commented: “We’re delighted to be launching our UK operation to improve the support we give to the UK-based clinicians, caregivers and engineers that use our innovative drug delivery and infusion products. By combining our market-proven technology with direct local support for training, repair, accessories, or any other customer needs, we can provide our valued customers with an integrated and holistic service that meets all of their infusion needs.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version